On the public citation graph
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
0 signed · 478 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1097-0142(197811)42:5<2352::aid-cncr2820420536>3.0.co;2-#openalex-snapshot
Characterization of an ovarian carcinoma cell line
inferredcites →https://doi.org/10.1002/ijc.21599openalex-snapshot
Molecular profiling of platinum resistant ovarian cancer
inferredcites →https://doi.org/10.1002/ijc.2910390607openalex-snapshot
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient
inferredcites →https://doi.org/10.1002/ijc.2910500114openalex-snapshot
Effects of interferons on the expression of the proto‐oncogene her‐2 in human ovarian carcinoma cells
inferredcites →https://doi.org/10.1002/ijc.2910530415openalex-snapshot
Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: Growth features and cytogenetics
inferredcites →https://doi.org/10.1002/jcb.23199openalex-snapshot
Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
inferredcites →https://doi.org/10.1002/path.2696openalex-snapshot
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
inferredcites →https://doi.org/10.1007/s00280-010-1462-2openalex-snapshot
Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts
inferredcites →https://doi.org/10.1007/s10549-009-0545-4openalex-snapshot
Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations
inferredcites →https://doi.org/10.1007/s10549-013-2415-3openalex-snapshot
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer
inferredcites →https://doi.org/10.1007/s10549-013-2529-7openalex-snapshot
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen
inferredcites →https://doi.org/10.1007/s10585-012-9482-4openalex-snapshot
CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
inferredcites →https://doi.org/10.1016/0090-8258(88)90276-4openalex-snapshot
Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro
inferredcites →https://doi.org/10.1016/j.ajpath.2010.12.043openalex-snapshot
Genotypic and Phenotypic Characterization of Side Population of Gastric Cancer Cell Lines
inferredcites →https://doi.org/10.1016/j.biocel.2009.10.016openalex-snapshot
Integrated genomics of chemotherapy resistant ovarian cancer: A role for extracellular matrix, TGFbeta and regulating microRNAs
inferredcites →https://doi.org/10.1016/j.ctrv.2013.10.001openalex-snapshot
The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets
inferredcites →https://doi.org/10.1016/j.drup.2012.01.006openalex-snapshot
The tumor microenvironment is a dominant force in multidrug resistance
inferredcites →https://doi.org/10.1016/j.ejca.2013.08.007openalex-snapshot
Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors
inferredcites →https://doi.org/10.1016/j.jaci.2013.08.032openalex-snapshot
Targeted next-generation sequencing: A novel diagnostic tool for primary immunodeficiencies
inferredcites →https://doi.org/10.1016/j.semcancer.2014.02.006openalex-snapshot
Prognostic relevance of cancer-associated fibroblasts in human cancer
inferredcites →https://doi.org/10.1016/j.ygyno.2010.01.010openalex-snapshot
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture
inferredcites →https://doi.org/10.1016/j.ygyno.2011.05.003openalex-snapshot
Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: Cytoplasmic sequestration of CDK2 by p27
inferredcites →https://doi.org/10.1016/j.ygyno.2012.06.017openalex-snapshot
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination
inferredcites →https://doi.org/10.1016/j.ygyno.2013.03.019openalex-snapshot
Notch3 induces epithelial–mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells
inferredcites →https://doi.org/10.1016/s0959-8049(11)70153-8openalex-snapshot
First line therapy: have we made any improvement?
inferredcites →https://doi.org/10.1016/s0959-8049(11)70155-1openalex-snapshot
The role of targeted therapy in ovarian cancer
inferredcites →https://doi.org/10.1038/bjc.1989.108openalex-snapshot
Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes
inferredcites →https://doi.org/10.1038/bjc.1996.428openalex-snapshot
Characterisation of seven human ovarian tumour cell lines
inferredcites →https://doi.org/10.1038/nature11003openalex-snapshot
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
inferredcites →https://doi.org/10.1038/nature11005openalex-snapshot
Systematic identification of genomic markers of drug sensitivity in cancer cells
inferredcites →https://doi.org/10.1038/nature11404openalex-snapshot
Comprehensive genomic characterization of squamous cell lung cancers
inferredcites →https://doi.org/10.1038/ncomms3126openalex-snapshot
Evaluating cell lines as tumour models by comparison of genomic profiles
inferredcites →https://doi.org/10.1038/nmeth.1516openalex-snapshot
Mutation discovery by targeted genomic enrichment of multiplexed barcoded samples
inferredcites →https://doi.org/10.1038/nprot.2011.396openalex-snapshot
Multiplexed array-based and in-solution genomic enrichment for flexible and cost-effective targeted next-generation sequencing
inferredcites →https://doi.org/10.1038/nrc3023openalex-snapshot
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
inferredcites →https://doi.org/10.1038/nrc3144openalex-snapshot
Rethinking ovarian cancer: recommendations for improving outcomes
inferredcites →https://doi.org/10.1038/nrgastro.2012.115openalex-snapshot
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
inferredcites →https://doi.org/10.1038/onc.2012.104openalex-snapshot
Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme
inferredcites →https://doi.org/10.1038/onc.2012.126openalex-snapshot
Fas signaling promotes motility and metastasis through epithelial–mesenchymal transition in gastrointestinal cancer
inferredcites →https://doi.org/10.1038/sj.onc.1202152openalex-snapshot
Mapping of chromosome 3p deletions in human epithelial ovarian tumors
inferredcites →https://doi.org/10.1074/mcp.m111.014647openalex-snapshot
The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
inferredcites →https://doi.org/10.1091/mbc.e12-04-0310openalex-snapshot
FilGAP, a Rho/Rho-associated protein kinase–regulated GTPase-activating protein for Rac, controls tumor cell migration
inferredcites →https://doi.org/10.1093/jnci/59.1.221openalex-snapshot
One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23
inferredcites →https://doi.org/10.1093/jnci/72.3.513openalex-snapshot
Characterization of a Cell Line Derived From the Ascites of a Patient With Papillary Serous Cystadenocarcinoma of the Ovary 2
inferredcites →https://doi.org/10.1093/jnci/87.7.506openalex-snapshot
Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
inferredcites →https://doi.org/10.1093/jnci/djn419openalex-snapshot
Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells
inferredcites →https://doi.org/10.1097/pgp.0b013e318161e4f5openalex-snapshot
Pathogenesis of Ovarian Cancer
inferredcites →https://doi.org/10.1098/rsob.120076openalex-snapshot
RhoB regulates cell migration through altered focal adhesion dynamics
inferredcites →https://doi.org/10.1101/cshperspect.a004903openalex-snapshot
Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
inferredcites →https://doi.org/10.1111/an.1999.40.2.6openalex-snapshot
The Massachusetts Institute of Technology
inferredcites →https://doi.org/10.1126/scitranslmed.3003726openalex-snapshot
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
inferredcites →https://doi.org/10.1158/0008-5472.can-04-3931openalex-snapshot
Stem and Progenitor-Like Cells Contribute to the Aggressive Behavior of Human Epithelial Ovarian Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-07-0575openalex-snapshot
Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression
inferredcites →https://doi.org/10.1158/0008-5472.can-11-3911openalex-snapshot
The Changing View of High-Grade Serous Ovarian Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-0196openalex-snapshot
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-0555openalex-snapshot
Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-2188openalex-snapshot
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
inferredcites →https://doi.org/10.1158/1541-7786.mcr-06-0234openalex-snapshot
Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation
inferredcites →https://doi.org/10.1158/1541-7786.mcr-10-0298openalex-snapshot
EphA2 Induces Metastatic Growth Regulating Amoeboid Motility and Clonogenic Potential in Prostate Carcinoma Cells
inferredcites →https://doi.org/10.1158/2159-8290.cd-11-0224openalex-snapshot
Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells
inferredcites →https://doi.org/10.1172/jci65833openalex-snapshot
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
inferredcites →https://doi.org/10.1186/1471-2407-6-201openalex-snapshot
Mismatch repair and treatment resistance in ovarian cancer
inferredcites →https://doi.org/10.1186/1475-2867-14-3openalex-snapshot
Sorting and identification of side population cells in the human cervical cancer cell line HeLa
inferredcites →https://doi.org/10.1186/1757-2215-4-6openalex-snapshot
Differential hRad17 expression by histologic subtype of ovarian cancer
inferredcites →https://doi.org/10.1186/gb-2009-10-6-r64openalex-snapshot
A novel and universal method for microRNA RT-qPCR data normalization
inferredcites →https://doi.org/10.1200/jco.2005.05.145openalex-snapshot
Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling
inferredcites →https://doi.org/10.1200/jco.2006.07.9970openalex-snapshot
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
inferredcites →https://doi.org/10.1290/1071-2690(2000)036<0357:cofneo>2.0.co;2openalex-snapshot
CHARACTERIZATION OF FOUR NOVEL EPITHELIAL OVARIAN CANCER CELL LINES
inferredcites →https://doi.org/10.1371/journal.pone.0008802openalex-snapshot
Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes
inferredcites →https://doi.org/10.1371/journal.pone.0013821openalex-snapshot
FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
inferredcites →https://doi.org/10.1371/journal.pone.0048344openalex-snapshot
Cooperative Anti-Invasive Effect of Cdc42/Rac1 Activation and ROCK Inhibition in SW620 Colorectal Cancer Cells with Elevated Blebbing Activity
inferredcites →https://doi.org/10.1371/journal.pone.0057692openalex-snapshot
N-Cadherin Expression Is Associated with Acquisition of EMT Phenotype and with Enhanced Invasion in Erlotinib-Resistant Lung Cancer Cell Lines
inferredcites →https://doi.org/10.1371/journal.pone.0072162openalex-snapshot
Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
inferredcites →https://doi.org/10.1593/neo.07229openalex-snapshot
Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
inferredcites →https://doi.org/10.17615/hvp3-wg08openalex-snapshot
Integrated genomic analyses of ovarian carcinoma
inferredcites →https://doi.org/10.4049/jimmunol.150.12.5219openalex-snapshot
Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative
inferredcites →https://doi.org/10.4161/cc.8.1.7533openalex-snapshot
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3947352openalex-extracted
The Lipid Kinase PI3Kα is Required for the Cohesion and Survival of Cancer Cells Disseminated in Serous Cavities
inferred← citeshttps://doi.org/10.1002/1878-0261.13612openalex-snapshot
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer
inferred← citeshttps://doi.org/10.1002/aisy.202400390openalex-snapshot
Clinically Informed Intelligent Classification of Ovarian Cancer Cells by Label‐Free Holographic Imaging Flow Cytometry
inferred← citeshttps://doi.org/10.1002/ame2.70280openalex-snapshot
Refining OVCAR ‐3 xenograft models of peritoneal carcinomatosis in nu/nu mice: Comparative intraperitoneal implantation strategies and the role of basement membrane matrix
inferred← citeshttps://doi.org/10.1002/aoc.5896openalex-snapshot
Ruthenium tetrazene complexes bearing glucose moieties on their periphery: Synthesis, characterization, and in vitro cytotoxicity
inferred← citeshttps://doi.org/10.1002/btm2.70082openalex-snapshot
Development and validation of a computational tool to predict treatment outcomes in cells from high‐grade serous ovarian cancer patients
inferred← citeshttps://doi.org/10.1002/cam4.1724openalex-snapshot
Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
inferred← citeshttps://doi.org/10.1002/cam4.3858openalex-snapshot
ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity
inferred← citeshttps://doi.org/10.1002/cam4.6521openalex-snapshot
Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
inferred← citeshttps://doi.org/10.1002/cbin.11352openalex-snapshot
In silico analysis of DYNLL1 expression in ovarian cancer chemoresistance
inferred← citeshttps://doi.org/10.1002/ijc.31186openalex-snapshot
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum‐response
inferred← citeshttps://doi.org/10.1002/jcp.26289openalex-snapshot
Molecular mechanisms of drug resistance in ovarian cancer
inferred← citeshttps://doi.org/10.1002/jcp.28775openalex-snapshot
Convergence of Wnt and Notch signaling controls ovarian cancer cell survival
inferred← citeshttps://doi.org/10.1002/mc.22735openalex-snapshot
Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer
inferred← citeshttps://doi.org/10.1002/mc.23843openalex-snapshot
The Role of SMAD7 in the Epigenetic Regulation of TGF‐β Targets in the Metastasis of Ovarian Cancer
inferred← citeshttps://doi.org/10.1002/path.6170openalex-snapshot
Targeting carcinoma‐associated mesothelial cells with antibody–drug conjugates in ovarian carcinomatosis
inferred← citeshttps://doi.org/10.1002/path.6223openalex-snapshot
Mechanisms of carboplatin‐ and paclitaxel‐dependent induction of premature senescence and pro‐cancerogenic conversion of normal peritoneal mesothelium and fibroblasts
inferred← citeshttps://doi.org/10.1002/pmic.202100372openalex-snapshot
Differential histone deacetylase inhibitor‐induced perturbations of the global proteome landscape in the setting of high‐grade serous ovarian cancer
inferred← citeshttps://doi.org/10.1002/smll.202100287openalex-snapshot
Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer
inferred← citeshttps://doi.org/10.1002/stem.2932openalex-snapshot
Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal Stroma
inferred← citeshttps://doi.org/10.1002/wsbm.1343openalex-snapshot
Mathematical models of breast and ovarian cancers
inferred← citeshttps://doi.org/10.1007/978-3-031-22802-5_8openalex-snapshot
Engineering Approaches in Ovarian Cancer Cell Culture
inferred← citeshttps://doi.org/10.1007/s00018-022-04395-yopenalex-snapshot
Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application
inferred← citeshttps://doi.org/10.1007/s00262-020-02544-5openalex-snapshot
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
inferred← citeshttps://doi.org/10.1007/s00262-022-03192-7openalex-snapshot
Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity
inferred← citeshttps://doi.org/10.1007/s00280-019-03988-yopenalex-snapshot
Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)
inferred← citeshttps://doi.org/10.1007/s10637-018-0641-6openalex-snapshot
Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro
inferred← citeshttps://doi.org/10.1007/s12015-025-11024-1openalex-snapshot
Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer
inferred← citeshttps://doi.org/10.1007/s12032-020-01383-9openalex-snapshot
Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype
inferred← citeshttps://doi.org/10.1007/s12032-024-02395-5openalex-snapshot
PARK2 suppresses the proliferation of high-grade serous ovarian carcinoma via inducing the proteasomal degradation of ZNF703
inferred← citeshttps://doi.org/10.1007/s12672-017-0316-3openalex-snapshot
The Interplay Between Epithelial-Mesenchymal Transition (EMT) and the Thyroid Hormones-αvβ3 Axis in Ovarian Cancer
inferred← citeshttps://doi.org/10.1007/s13258-022-01314-0openalex-snapshot
Rab11a promotes the malignant progression of ovarian cancer by inducing autophagy
inferred← citeshttps://doi.org/10.1007/s13273-024-00451-9openalex-snapshot
Cucurbitacin-I exhibits anticancer activity by inducing apoptosis in SKOV3 human ovarian cancer cells
inferred← citeshttps://doi.org/10.1007/s13402-020-00514-8openalex-snapshot
The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis
inferred← citeshttps://doi.org/10.1007/s13402-025-01102-4openalex-snapshot
Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens
inferred← citeshttps://doi.org/10.1007/s13577-017-0162-1openalex-snapshot
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line
inferred← citeshttps://doi.org/10.1016/b978-0-12-819840-7.00012-1openalex-snapshot
Models of ovarian cancer to test new agents
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2024.119801openalex-snapshot
Reprogramming of normal fibroblasts into ovarian cancer-associated fibroblasts via non-vesicular paracrine signaling induces an activated fibroblast phenotype
inferred← citeshttps://doi.org/10.1016/j.bbrc.2019.01.117openalex-snapshot
Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.bbrep.2024.101906openalex-snapshot
Exploring miRNA profile associated with cisplatin resistance in ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.119908openalex-snapshot
Development of a near infrared protein nanoprobe targeting Thomsen-Friedenreich antigen for intraoperative detection of submillimeter nodules in an ovarian peritoneal carcinomatosis mouse model
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.120610openalex-snapshot
A biomimetic model of 3D fluid extracellular macromolecular crowding microenvironment fine-tunes ovarian cancer cells dissemination phenotype
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.117069openalex-snapshot
Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118278openalex-snapshot
Exploring the role of estrogens and steroid sulfatase inhibition in platinum resistance, proliferation, migration, and cell death in high-grade serous ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.bmc.2018.03.007openalex-snapshot
High expression of integrin αvβ3 enables uptake of targeted fluorescent probes into ovarian cancer cells and tumors
inferred← citeshttps://doi.org/10.1016/j.canlet.2015.03.040openalex-snapshot
Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.canlet.2015.08.012openalex-snapshot
Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.10.035openalex-snapshot
PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers
inferred← citeshttps://doi.org/10.1016/j.cell.2024.10.047openalex-snapshot
ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization
inferred← citeshttps://doi.org/10.1016/j.cellsig.2023.110634openalex-snapshot
The adaptor protein VEPH1 interacts with the kinase domain of ERBB2 and impacts EGF signaling in ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.celrep.2020.107532openalex-snapshot
Super-Enhancer Redistribution as a Mechanism of Broad Gene Dysregulation in Repeatedly Drug-Treated Cancer Cells
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109815openalex-snapshot
Shift in MSL1 alternative polyadenylation in response to DNA damage protects cancer cells from chemotherapeutic agent-induced apoptosis
inferred← citeshttps://doi.org/10.1016/j.cels.2020.04.007openalex-snapshot
CELLector: Genomics-Guided Selection of Cancer In Vitro Models
inferred← citeshttps://doi.org/10.1016/j.cels.2023.05.003openalex-snapshot
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2025.110445openalex-snapshot
Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60
inferred← citeshttps://doi.org/10.1016/j.drudis.2025.104331openalex-snapshot
Ramipril, perindopril and trandolapril as potential chemosensitizers in ovarian cancer: Considerations for drug repurposing
inferred← citeshttps://doi.org/10.1016/j.drup.2015.11.005openalex-snapshot
Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions
inferred← citeshttps://doi.org/10.1016/j.ebiom.2020.102782openalex-snapshot
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejcsup.2019.11.003openalex-snapshot
The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.03.078openalex-snapshot
Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116365openalex-snapshot
Identification of a new bisindolinone arresting IGROV1 cells proliferation
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.118056openalex-snapshot
Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics
inferred← citeshttps://doi.org/10.1016/j.ejso.2024.108549openalex-snapshot
Current status of in vitro models for rare gynaecological cancer research
inferred← citeshttps://doi.org/10.1016/j.eujim.2020.101163openalex-snapshot
Pretreatment with methanolic extract of Pistacia lentiscus L. increases sensitivity to DNA damaging drugs in primary high-grade serous ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.isci.2024.111283openalex-snapshot
Distinct effects of sacituzumab govitecan and berzosertib on DNA damage response in ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.101890openalex-snapshot
Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
inferred← citeshttps://doi.org/10.1016/j.jcis.2022.05.005openalex-snapshot
S, N-doped carbon dots-based cisplatin delivery system in adenocarcinoma cells: Spectroscopical and computational approach
inferred← citeshttps://doi.org/10.1016/j.jconrel.2019.08.034openalex-snapshot
Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article
inferred← citeshttps://doi.org/10.1016/j.jep.2021.114706openalex-snapshot
The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2019.105492openalex-snapshot
Effect of progesterone and first evidence about allopregnanolone action on the progression of epithelial human ovarian cancer cell lines
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2025.106900openalex-snapshot
Context-dependent effects of progesterone 4-pregnene metabolites on apoptosis and proliferation in ovarian cancer cell lines IGROV-1 and SK-OV-3
inferred← citeshttps://doi.org/10.1016/j.lfs.2023.122166openalex-snapshot
Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway
inferred← citeshttps://doi.org/10.1016/j.matbio.2023.02.004openalex-snapshot
Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology
inferred← citeshttps://doi.org/10.1016/j.mcpro.2023.100660openalex-snapshot
Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis
inferred← citeshttps://doi.org/10.1016/j.nano.2018.03.005openalex-snapshot
Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin
inferred← citeshttps://doi.org/10.1016/j.nano.2020.102309openalex-snapshot
Nanoparticle delivery systems to combat drug resistance in ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.neo.2018.12.005openalex-snapshot
MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells
inferred← citeshttps://doi.org/10.1016/j.omtn.2022.09.012openalex-snapshot
Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.omton.2024.200911openalex-snapshot
Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.optlastec.2024.110920openalex-snapshot
Improving cellular analysis throughput of lens-free holographic microscopy with circular Hough transform and convolutional neural networks
inferred← citeshttps://doi.org/10.1016/j.phymed.2019.152847openalex-snapshot
Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.prp.2025.155911openalex-snapshot
Chemo-sensitive and chemo-resistant ovarian cancer cells show differences in cellular processes leading to pyroptotic cell death
inferred← citeshttps://doi.org/10.1016/j.semcancer.2017.08.003openalex-snapshot
Epigenetics in ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.semcancer.2020.08.005openalex-snapshot
Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers
inferred← citeshttps://doi.org/10.1016/j.semcancer.2021.02.007openalex-snapshot
Targeting the tumour microenvironment in platinum-resistant ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.tranon.2025.102522openalex-snapshot
Novel p53 reactivators that are synergistic with olaparib for the treatment of gynecologic cancers with mutant p53
inferred← citeshttps://doi.org/10.1016/j.trecan.2020.07.007openalex-snapshot
Human-Derived Model Systems in Gynecological Cancer Research
inferred← citeshttps://doi.org/10.1016/j.xpro.2025.104095openalex-snapshot
Protocol for iterative in vivo selection of highly metastatic ovarian cancer cell populations and metastasis modeling in mice
inferred← citeshttps://doi.org/10.1016/j.yexcr.2020.112167openalex-snapshot
Nicotine inhibits MAPK signaling and spheroid invasion in ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.yexcr.2025.114656openalex-snapshot
Constructing a co-culture model of cancer-associated fibroblasts and ovarian cancer organoids and studying mechanisms of drug resistance
inferred← citeshttps://doi.org/10.1016/j.ygeno.2015.09.001openalex-snapshot
DNA methylation changes in epithelial ovarian cancer histotypes
inferred← citeshttps://doi.org/10.1016/j.ygyno.2015.04.014openalex-snapshot
Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays
inferred← citeshttps://doi.org/10.1016/j.ygyno.2015.05.040openalex-snapshot
In vivo tumor growth of high-grade serous ovarian cancer cell lines
inferred← citeshttps://doi.org/10.1016/j.ygyno.2015.06.018openalex-snapshot
Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.ygyno.2016.05.028openalex-snapshot
Characterization of ovarian cancer cell lines as in vivo models for preclinical studies
inferred← citeshttps://doi.org/10.1016/j.ygyno.2017.12.018openalex-snapshot
Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target
inferred← citeshttps://doi.org/10.1016/j.ygyno.2019.12.033openalex-snapshot
Low-grade serous ovarian cancer: State of the science
inferred← citeshttps://doi.org/10.1016/j.ygyno.2020.03.010openalex-snapshot
Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer
inferred← citeshttps://doi.org/10.1016/j.ygyno.2020.10.044openalex-snapshot
Evaluation of publicly available in vitro drug sensitivity models for ovarian and uterine cancer
inferred← citeshttps://doi.org/10.1016/j.ygyno.2021.04.003openalex-snapshot
Understanding the effect of mechanical forces on ovarian cancer progression
inferred← citeshttps://doi.org/10.1016/j.ygyno.2022.01.008openalex-snapshot
Dubious effects of methadone as an “anticancer” drug on ovarian cancer cell-lines and patient-derived tumor-spheroids
inferred← citeshttps://doi.org/10.1016/j.ygyno.2023.08.004openalex-snapshot
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment
inferred← citeshttps://doi.org/10.1016/j.ygyno.2024.03.029openalex-snapshot
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma
inferred← citeshttps://doi.org/10.1021/acs.analchem.3c02506openalex-snapshot
Single-Cell ICP-MS in Combination with Fluorescence-Activated Cell Sorting for Investigating the Effects of Nanotransported Cisplatin(IV) Prodrugs
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c02107openalex-snapshot
Folic Acid–Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00930openalex-snapshot
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.3c00397openalex-snapshot
Effect of Polyplex Size on Penetration into Tumor Spheroids
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.6b00205openalex-snapshot
Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.7b00843openalex-snapshot
Ratio-Dependent Synergism of a Doxorubicin and Olaparib Combination in 2D and Spheroid Models of Ovarian Cancer
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.8b00246openalex-snapshot
BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.2c00879openalex-snapshot
Three-Dimensional Collagen Topology Shapes Cell Morphology, beyond Stiffness
inferred← citeshttps://doi.org/10.1021/acschembio.5b00513openalex-snapshot
[Cu(o-phthalate)(phenanthroline)] Exhibits Unique Superoxide-Mediated NCI-60 Chemotherapeutic Action through Genomic DNA Damage and Mitochondrial Dysfunction
inferred← citeshttps://doi.org/10.1021/acsptsci.0c00064openalex-snapshot
Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior
inferred← citeshttps://doi.org/10.1038/bjc.2015.471openalex-snapshot
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
inferred← citeshttps://doi.org/10.1038/bjc.2017.51openalex-snapshot
VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation
inferred← citeshttps://doi.org/10.1038/ncomms12645openalex-snapshot
Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status
inferred← citeshttps://doi.org/10.1038/ncomms8002openalex-snapshot
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
inferred← citeshttps://doi.org/10.1038/ncomms9583openalex-snapshot
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas
inferred← citeshttps://doi.org/10.1038/nrc4019openalex-snapshot
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
inferred← citeshttps://doi.org/10.1038/onc.2015.288openalex-snapshot
YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
inferred← citeshttps://doi.org/10.1038/s41388-021-01710-yopenalex-snapshot
Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
inferred← citeshttps://doi.org/10.1038/s41388-025-03466-1openalex-snapshot
LOXL2 reduces susceptibility to PARP inhibitors by promoting super-enhancer-regulated DNA damage repair in high-grade serous ovarian cancer
inferred← citeshttps://doi.org/10.1038/s41416-020-0825-7openalex-snapshot
Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1
inferred← citeshttps://doi.org/10.1038/s41417-023-00590-6openalex-snapshot
Suicide gene strategies applied in ovarian cancer studies
inferred← citeshttps://doi.org/10.1038/s41417-025-00941-5openalex-snapshot
Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer
inferred← citeshttps://doi.org/10.1038/s41420-024-01858-yopenalex-snapshot
CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation
inferred← citeshttps://doi.org/10.1038/s41467-018-03590-5openalex-snapshot
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
inferred← citeshttps://doi.org/10.1038/s41540-022-00230-zopenalex-snapshot
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
inferred← citeshttps://doi.org/10.1038/s41556-019-0442-yopenalex-snapshot
TRIP13 regulates DNA repair pathway choice through REV7 conformational change
inferred← citeshttps://doi.org/10.1038/s41598-017-07005-1openalex-snapshot
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
inferred← citeshttps://doi.org/10.1038/s41598-017-16593-xopenalex-snapshot
Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
inferred← citeshttps://doi.org/10.1038/s41598-018-34471-yopenalex-snapshot
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6
inferred← citeshttps://doi.org/10.1038/s41598-018-34696-xopenalex-snapshot
Comparison of cell-based assays to quantify treatment effects of anticancer drugs identifies a new application for Bodipy-L-cystine to measure apoptosis
inferred← citeshttps://doi.org/10.1038/s41598-019-41941-4openalex-snapshot
Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas
inferred← citeshttps://doi.org/10.1038/s41598-021-86681-6openalex-snapshot
TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells
inferred← citeshttps://doi.org/10.1038/s41598-021-97434-wopenalex-snapshot
Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models
inferred← citeshttps://doi.org/10.1038/s41598-022-15234-2openalex-snapshot
Differential epithelial and stromal LGR5 expression in ovarian carcinogenesis
inferred← citeshttps://doi.org/10.1038/s41598-023-44548-yopenalex-snapshot
The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer
inferred← citeshttps://doi.org/10.1038/s41598-026-67317-zopenalex-snapshot
Metabolomic and biochemometric profiling of Tecoma stans with mechanistic insights of its in vitro cytotoxic activity
inferred← citeshttps://doi.org/10.1038/s42003-019-0506-3openalex-snapshot
The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells
inferred← citeshttps://doi.org/10.1038/s42003-023-05045-0openalex-snapshot
The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
inferred← citeshttps://doi.org/10.1038/srep12642openalex-snapshot
Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals
inferred← citeshttps://doi.org/10.1038/srep36873openalex-snapshot
Protein tyrosine phosphatase PTPN3 promotes drug resistance and stem cell-like characteristics in ovarian cancer
inferred← citeshttps://doi.org/10.1039/c9mt00187eopenalex-snapshot
Cu( ii ) phenanthroline–phenazine complexes dysregulate mitochondrial function and stimulate apoptosis
inferred← citeshttps://doi.org/10.1039/d2np00091aopenalex-snapshot
Discovery and development of botanical natural products and their analogues as therapeutics for ovarian cancer
inferred← citeshttps://doi.org/10.1039/d3an00398aopenalex-snapshot
Improving SERS biosensors for the analysis of ovarian cancer-derived small extracellular vesicles
inferred← citeshttps://doi.org/10.1051/bioconf/202623301001openalex-snapshot
Comparative Evaluation of 1,8 cineole on inhibition and migration of Human Ovarian Cancer Cell Lines SKOV3 and PA-1
inferred← citeshttps://doi.org/10.1055/a-0706-7503openalex-snapshot
Mechanism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells
inferred← citeshttps://doi.org/10.1073/pnas.2418096121openalex-snapshot
Loss of XIST lncRNA unlocks stemness and cellular plasticity in ovarian cancer
inferred← citeshttps://doi.org/10.1080/01635581.2018.1380203openalex-snapshot
Active Hexose Correlated Compound (AHCC) Inhibits the Proliferation of Ovarian Cancer Cells by Suppressing Signal Transducer and Activator of Transcription 3 (STAT3) Activation
inferred← citeshttps://doi.org/10.1080/07391102.2024.2310776openalex-snapshot
Computational investigations into structure and function impact of novel mutations identified in targeted exons from ovarian cancer cell lines
inferred← citeshttps://doi.org/10.1080/14728222.2018.1512587openalex-snapshot
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
inferred← citeshttps://doi.org/10.1080/14786419.2026.2613771openalex-snapshot
Anti-cancer potential of polysaccharides derived from Tetrastigma hemsleyanum Diels et Gilg against human ovarian cancer cells in vitro
inferred← citeshttps://doi.org/10.1080/15384101.2017.1295181openalex-snapshot
Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells
inferred← citeshttps://doi.org/10.1080/15384101.2022.2109362openalex-snapshot
CCNE1 is a potential target of Metformin for tumor suppression of ovarian high-grade serous carcinoma
inferred← citeshttps://doi.org/10.1080/2162402x.2021.1981049openalex-snapshot
CD34 + progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg null mice
inferred← citeshttps://doi.org/10.1080/21655979.2022.2064652openalex-snapshot
Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/Smad2 signaling
inferred← citeshttps://doi.org/10.1089/nat.2014.0522openalex-snapshot
Identification of Epithelial Ovarian Tumor-Specific Aptamers
inferred← citeshttps://doi.org/10.1093/biomethods/bpad029openalex-snapshot
Serum starvation-based method of ovarian cancer cell dormancy induction and termination in vitro
inferred← citeshttps://doi.org/10.1093/carcin/bgz119openalex-snapshot
Functional balance between Tcf21–Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines
inferred← citeshttps://doi.org/10.1093/jnci/djv161openalex-snapshot
MicroRNA regulation of RAD51 in serous ovarian cancer modulates chemotherapy response
inferred← citeshttps://doi.org/10.1093/nar/gkaa048openalex-snapshot
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
inferred← citeshttps://doi.org/10.1097/pgp.0000000000000537openalex-snapshot
A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel
inferred← citeshttps://doi.org/10.1101/2020.07.14.202457openalex-snapshot
Classification of ovarian cancer cell lines using transcriptional profiles defines the five major pathological subtypes
inferred← citeshttps://doi.org/10.1101/2022.01.26.477902openalex-snapshot
Topology of Connective Tissues: A Key Parameter in Cellular Heterogeneity, Beyond Composition and Stiffness
inferred← citeshttps://doi.org/10.1101/2022.09.02.506330openalex-snapshot
Elevated levels of lamin A promote HR and NHEJ-mediated repair mechanisms in etoposide-treated ovarian cancer cells
inferred← citeshttps://doi.org/10.1101/2023.03.22.533721openalex-snapshot
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling
inferred← citeshttps://doi.org/10.1101/2024.07.26.605381openalex-snapshot
Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models
inferred← citeshttps://doi.org/10.1101/2025.10.10.681642openalex-snapshot
Reduced 4E-BP1 activity leads to acquired capivasertib resistance via increased cap-dependent protein synthesis
inferred← citeshttps://doi.org/10.1101/777649openalex-snapshot
The lipid kinase PI3Kα is required for the cohesion and survival of cancer cells disseminated in serous cavities
inferred← citeshttps://doi.org/10.1101/cshperspect.a041949openalex-snapshot
Models of High-Grade Serous Ovarian Carcinoma
inferred← citeshttps://doi.org/10.1111/cpr.13029openalex-snapshot
Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis
inferred← citeshttps://doi.org/10.1111/cpr.13582openalex-snapshot
MET overexpression in ovarian cancer via CD24 ‐induced downregulation of miR ‐181a: A signalling for cellular quiescence‐like state and chemoresistance in ovarian CSCs
inferred← citeshttps://doi.org/10.1111/cts.12413openalex-snapshot
PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines
inferred← citeshttps://doi.org/10.1111/fcp.12709openalex-snapshot
The cyclin‐dependent kinase inhibitor AT7519 augments cisplatin's efficacy in ovarian cancer via multiple oncogenic signaling pathways
inferred← citeshttps://doi.org/10.1111/jcmm.71334openalex-snapshot
Genome‐Wide Assessment of DNA Methylation Fidelity Identifies Representative Ovarian Cancer Cell Line Models
inferred← citeshttps://doi.org/10.1124/jpet.124.002298openalex-snapshot
VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis
inferred← citeshttps://doi.org/10.1134/s1022795420070091openalex-snapshot
Two Mutations in TP53 Promotes Migration, Invasion, and Proliferation of Human Ovarian Cancer A2780 Cells
inferred← citeshttps://doi.org/10.1134/s1068162024606694openalex-snapshot
Combined Effects of Cytokine TRAIL-Based DR5-Specific Fusion Protein with Olaparib on Tumor Cell Lines with Different BRCA Mutation Status
inferred← citeshttps://doi.org/10.1155/2020/3145182openalex-snapshot
Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells
inferred← citeshttps://doi.org/10.1155/omcl/6333148openalex-snapshot
Suppression of Paclitaxel‐Induced Neuropathy and Ovarian Tumor Growth by Mn Porphyrin, MnTnBuOE‐2‐PyP 5+ (BMX‐001)
inferred← citeshttps://doi.org/10.1158/0008-5472.c.6512719.v1openalex-snapshot
Data from Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1-Deficient Cells
inferred← citeshttps://doi.org/10.1158/0008-5472.can-18-2674openalex-snapshot
Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers
inferred← citeshttps://doi.org/10.1158/0008-5472.can-18-3029openalex-snapshot
Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma
inferred← citeshttps://doi.org/10.1158/0008-5472.can-19-0215openalex-snapshot
Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer
inferred← citeshttps://doi.org/10.1158/0008-5472.can-20-2912openalex-snapshot
Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1 -Deficient Cells
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-16-0620openalex-snapshot
Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-16-0444openalex-snapshot
Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3- d ]pyrimidine Antifolates
inferred← citeshttps://doi.org/10.1158/1541-7786.22526954openalex-snapshot
Supplementary Table 2 from CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP Inhibitors
inferred← citeshttps://doi.org/10.1158/1541-7786.22526957.v1openalex-snapshot
Supplementary Table 1 from CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP Inhibitors
inferred← citeshttps://doi.org/10.1158/1541-7786.mcr-15-0431openalex-snapshot
Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming
inferred← citeshttps://doi.org/10.1158/1541-7786.mcr-20-0791openalex-snapshot
CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP Inhibitors
inferred← citeshttps://doi.org/10.1158/1541-7786.mcr-21-0302openalex-snapshot
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress
inferred← citeshttps://doi.org/10.1158/2767-9764.crc-24-0215openalex-snapshot
IMGN853 Induces Autophagic Cell Death in Combination Therapy for Ovarian Cancer
inferred← citeshttps://doi.org/10.1158/2767-9764.crc-25-0193openalex-snapshot
Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcome Disparities in High-Grade Endometrial Cancer
inferred← citeshttps://doi.org/10.1172/jci142677openalex-snapshot
Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer
inferred← citeshttps://doi.org/10.1172/jci145035openalex-snapshot
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer
inferred← citeshttps://doi.org/10.1186/s12885-017-3246-0openalex-snapshot
Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
inferred← citeshttps://doi.org/10.1186/s12885-018-4613-1openalex-snapshot
Mutant p53 gain of function induces HER2 over-expression in cancer cells
showing the first 200 of 398 · page through all 398
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.